Filters
Other countries
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
GDF5 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 8 | 1 |
|
Invitae Skeletal Disorders Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 624 | 349 |
|
Invitae Limb and Digital Malformations Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 356 | 177 |
|
Polydactyly and Syndactyly Panel PreventionGenetics, part of Exact Sciences United States | 320 | 231 |
|
PreventionGenetics, part of Exact Sciences United States | 231 | 139 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
PreventionGenetics, part of Exact Sciences United States | 220 | 128 |
|
Invitae Comprehensive Carrier Screen Labcorp Genetics (formerly Invitae) LabCorp United States | 886 | 547 |
|
GDF5-related Disorders via the GDF5 Gene PreventionGenetics, part of Exact Sciences United States | 6 | 1 |
|
Limb malformation panel. NGS panel of 45 genes. Genologica Medica Spain | 77 | 45 |
|
Craniosynostosis panel. NGS panel of 37 genes. Genologica Medica Spain | 113 | 37 |
|
Central skeletal dysplasias panel. NGS panel of 111 genes. Genologica Medica Spain | 258 | 111 |
|
Micromelic dysplasia panel. NGS panel of 27 genes. Genologica Medica Spain | 83 | 27 |
|
Brachydactyly / syndactyly panel. NGS panel of 20 genes. Genologica Medica Spain | 55 | 20 |
|
Skeletal diseases. NGS panel of 169 genes. Genologica Medica Spain | 373 | 169 |
|
Chondrodysplasia: Full gene sequencing panel CEN4GEN Institute for Genomics and Molecular Diagnostics Canada | 5 | 5 |
|
Micromelic Dysplasia NGS Panel Fulgent Genetics United States | 140 | 25 |
|
Blueprint Genetics Finland | 6 | 27 |
|
Potentially lethal skeletal disorders Panel CeGaT GmbH Germany | 45 | 44 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.